SpringWorks Therapeutics Inc (SWTX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -87.677 | -60.412 | -26.396 | -10.005 | -33.812 | -51.244 | -47.949 |
Return on Equity (%) | 353.448 | 161.981 | -33.417 | -10.368 | -35.512 | -56.582 | -54.897 |
Return on Invested Capital (%) | -93.866 | -70.513 | -34.181 | -11.493 | -40.842 | -62.806 | -71.659 |
Operating Margin (%) | N/A | N/A | N/A | -130.211 | N/A | N/A | -5968.496 |
Net Profit Margin (%) | N/A | N/A | N/A | -130.211 | N/A | N/A | -5968.496 |
Book Value Per Share | N/A | N/A | 6.514 | 10.081 | 7.585 | 8.106 | 9.073 |
Earnings Per Share | N/A | N/A | -1.023 | -0.825 | -3.123 | -4.029 | -4.71 |
Cash Per Share | N/A | N/A | 6.627 | 2.662 | 1.867 | 0.98 | 2.551 |
Working Capital Per Share | N/A | N/A | 6.46 | 8.972 | 6.338 | 7.968 | 6.125 |
Operating Profit Per Share | N/A | N/A | N/A | 0.633 | N/A | N/A | 0.073 |
EBIT Per Share | N/A | N/A | -1.179 | -0.825 | -3.123 | -4.029 | -4.71 |
EBITDA Per Share | N/A | N/A | -1.179 | -0.825 | -3.123 | -4.029 | -4.71 |
Free Cash Flow Per Share | N/A | N/A | -1.013 | -0.819 | -3.096 | -3.892 | -4.627 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | 43,01M | 48,82M | 49,25M | 62,42M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 62,42M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -416 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -416 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,84B |
Ratio cours/bénéfice | -8,89 |
Ratio prix/ventes | 531,01 |
Ratio prix/liquidités | 16,42 |
Ratio prix/valeur comptable | 4,62 |
Rendement de dividende | - |
Actions en circulation | 74,39M |
Volume moyen (1 semaine) | 733,52k |
Volume moyen (1 mois) | 962,54k |
Variation sur 52 semaines | 2,60% |
Plus haut sur 52 semaines | 53,92 |
Plus bas sur 52 semaines | 28,21 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales